首页> 外文期刊>Frontiers in Medicine >Oral Probiotics Alleviate Intestinal Dysbacteriosis for People Receiving Bowel Preparation
【24h】

Oral Probiotics Alleviate Intestinal Dysbacteriosis for People Receiving Bowel Preparation

机译:口腔益生菌缓解肠道缺乏症,用于接受肠道准备的人

获取原文
       

摘要

Background: Bowel preparation is necessary for successful colonoscopy, while it can seriously affect intestinal microbial composition and damage the intestinal mucosal barriers in humans. Methods: To figure out whether probiotics can sustain intestinal homeostasis and guard people's health, the probiotic drug of Bifidobacterium Tetragenous viable Bacteria Tablets (P group, n = 16) or placebo (C group, n = 16) was used for volunteers receiving bowel preparation, and high-throughput sequencing method was applied to monitor their intestinal microbial changes. Results: The present results suggested that bowel preparation obviously reduced the intestinal microbial diversity, while taking probiotics significantly restored it to normal level. In addition, probiotics sharply reduced the abundance of pathogenic Proteobacteria , and obviously lowered the ratio of Firmicutes/Bacteroidetes compared with control group at phylum level ( P 0.05). And probiotics markedly decreased the abundance of pathogenic Acinetobacter and Streptococcus , while greatly enriched the relative abundance of beneficial bacteria Bacteroides, Roseburia, Faecalibacterium , and Parabacteroides at genus level ( P 0.05). Conclusion: Probiotic drugs, e.g., Bifidobacterium Tetragenous viable Bacteria Tablets, can be used to restore intestinal dysbacteriosis caused by bowel preparation, and reduce side effects during colonoscopy.
机译:背景:肠道准备是成功结肠镜检查所必需的,同时它可以严重影响肠道微生物组合物并损害人类的肠粘膜屏障。方法:要弄清楚是否能够维持肠道稳态和保护人们的健康,使双歧杆菌活细菌片剂(P组,N = 16)或安慰剂(C组,N = 16)的益生菌药用于接受肠道制剂的志愿者并且应用高通量测序方法监测其肠道微生物变化。结果:目前的结果表明,肠道准备明显降低了肠道微生物多样性,同时服用益生菌明显恢复到正常水平。此外,益生菌急剧降低了致病型植物的丰富性,并且与场米水平的对照组相比明显降低了对照组(P <0.05)的对照组比较。益生菌显着降低了致病性传导和链球菌的丰富性,而大大富集了有益细菌诱发的菌,Rosebura,粪术和在属级别的粉刺(P <0.05)。结论:益生菌药物,例如四偏瘫可行性细菌片剂,可用于恢复肠道制剂引起的肠炎症,并在结肠镜检查期间减少副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号